Johnson & Johnson in talks to acquire Olin Biosciences for up to $3.4 billion
JNJ Johnson & Johnson
$285.75 +0.79%
View chart & analysis → - 1Johnson & Johnson is engaged in advanced negotiations to acquire Olin Biosciences.
- 2The deal could include a $2.2 billion upfront cash payment and up to $1.2 billion in milestone payments from Johnson & Johnson.
- 3IDP Education has rejected Blackstone's $564.5 million acquisition offer for the third time.
So what's the key point?
What is the main point? Johnson & Johnson is negotiating to buy Olin Biosciences. They are looking to acquire the company for up to $3.4 billion.
Source Investing.com · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.